Selected article for: "International license and significant difference"

Author: Guosheng Yin; Huaqing Jin
Title: Comparison of transmissibility of coronavirus between symptomatic and asymptomatic patients: Reanalysis of the Ningbo Covid-19 data
  • Document date: 2020_4_7
  • ID: nlzdto1h_17
    Snippet: In summary, we provide a more in-depth analysis of the Ningbo Covid-19 data to examine the difference in the transmissibility of coronavirus for symptomatic and asymptomatic patients. We adopt more appropriate statistical methods, such as Fisher's exact tests, which require no assumptions on the cell counts in the contingency table. We provide the odds ratio, estimated transmission rates, as well as the corresponding 95% confidence intervals, and.....
    Document: In summary, we provide a more in-depth analysis of the Ningbo Covid-19 data to examine the difference in the transmissibility of coronavirus for symptomatic and asymptomatic patients. We adopt more appropriate statistical methods, such as Fisher's exact tests, which require no assumptions on the cell counts in the contingency table. We provide the odds ratio, estimated transmission rates, as well as the corresponding 95% confidence intervals, and the conclusions remain the same that there is no statistically significant difference in the transmissibility of coronavirus between symptomatic and asymptomatic patients. . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • appropriate statistical method and depth analysis: 1
    • appropriate statistical method and exact test: 1
    • appropriate statistical method and statistical method: 1, 2, 3, 4
    • asymptomatic symptomatic patient and confidence interval: 1
    • cc international license and cell count: 1, 2, 3, 4, 5, 6
    • cc international license and confidence interval: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • cc international license and contingency table: 1
    • cc international license and depth analysis: 1
    • cc international license and exact test: 1, 2, 3, 4, 5, 6, 7
    • cc international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc international license and statistical method: 1, 2, 3, 4
    • cc international license and statistically significant difference: 1, 2, 3, 4
    • cell count and confidence interval: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell count and depth analysis: 1
    • cell count and exact test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cell count and international license: 1, 2, 3, 4, 5, 6
    • cell count and statistical method: 1
    • cell count and statistically significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • confidence interval and contingency table: 1